The Patent Finder

Cardiorentis AG

Also on record
Records under this name other than patents Cardiorentis AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Cardiorentis AG

PatentTitleStatus Expires Confidence
US 7,732,406Use of Natriuretic Peptide for Treating Heart Failure
Term ended
Term ended Nov 17, 2026 · High confidence
Term endedTerm ended Nov 17, 2026High confidence
US 8,710,006Use of natriuretic peptide for treating heart failure
Lapsed on the fee record
Ended Apr 29, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 29, 2026From the USPTO record
US 9,023,794Use of natriuretic peptide for treating heart failure
Term ended
Ended no later than Apr 7, 2026 · From the USPTO record
Term endedEnded no later than Apr 7, 2026From the USPTO record
US 9,358,271Use of natriuretic peptide for treating heart failure
Term ended
Ended no later than Apr 7, 2026 · From the USPTO record
Term endedEnded no later than Apr 7, 2026From the USPTO record
US 8,293,711Use of natriuretic peptides for treating angioedema syndromes
Lapsed on the fee record
Ended Oct 23, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 23, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited